Synthesis of N-(2-chloro-5-methylthiophenyl)-N′-(3-methyl-thiophenyl)-N′-[3H3]methylguanidine, {[3H3]CNS-5161}

被引:5
|
作者
Gibbs, AR
Morimoto, H
VanBrocklin, HF
Williams, PG
Biegon, A
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Funct Imaging, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Tritium Labeling Facil, Berkeley, CA 94720 USA
来源
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2002年 / 45卷 / 05期
关键词
CNS-5161; tritium; NMDA;
D O I
10.1002/jlcr.561
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The preparation of the title compound, [H-3(3)]CNS-5161, was accomplished in three steps starting with the production of [H-3(3)]iodomethane (CT3I). The intermediate N-[H-3(3)]methyl-3-(thiomethylphenyl)cyanamide was prepared in 77% yield by the addition of CT3I to 3-(thiomethylphenyl)cyanamide, previously treated with sodium hydride. Reaction of this tritiated intermediate with 2-chloro-5-thiomethylaniline hydrochloride formed the guanidine compound [H-3(3)]CNS-5161. Purification by HPLC gave the desired labeled product in an overall yield of 9% with > 96% radiochemical purity and a final specific activity of 66 Ci mmol(-1). Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:395 / 400
页数:6
相关论文
共 50 条